Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 4,960,000 shares, a drop of 9.8% from the March 15th total of 5,500,000 shares. Approximately 4.8% of the shares of the stock are sold short. Based on an average daily […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 4,960,000 shares, a decline of 9.8% from the March 15th total of 5,500,000 shares. Based on an average daily trading volume, of 1,100,000 shares, the days-to-cover ratio […]
Kornitzer Capital Management Inc. KS bought a new position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) during the fourth quarter, Holdings Channel reports. The institutional investor bought 98,820 shares of the biotechnology company’s stock, valued at approximately $4,008,000. A number of other institutional investors and hedge funds also recently modified their holdings […]
SVB Leerink upgraded shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating) from a market perform rating to an outperform rating in a report published on Wednesday morning, PriceTargets.com reports. SVB Leerink also issued estimates for Arrowhead Pharmaceuticals’ Q2 2023 earnings at ($0.02) EPS, Q3 2023 earnings at ($0.02) EPS, Q4 2023 earnings at $0.33 EPS, […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) gapped up before the market opened on Wednesday . The stock had previously closed at $26.23, but opened at $27.81. Arrowhead Pharmaceuticals shares last traded at $29.58, with a volume of 470,763 shares changing hands. Analysts Set New Price Targets A number of equities research analysts have weighed […]